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Context:Genes from the ovarian bonemorphogenetic signaling path-
way (GDF9 and BMP15) are critical for normal human fertility. We
previously identified a deletion mutation in GDF9 in sisters with
spontaneous dizygotic (DZ) twins, but the prevalence of rare GDF9
variants in twinning families is unknown.
Objective: The objective was to evaluate the frequency of rare vari-
ants in GDF9 in families with a history of DZ twinning.
Design and Subjects: We recruited 3450 individuals from 915 DZ
twinning families (1693 mothers of twins) and 1512 controls of Cauca-
sian origin. One mother of DZ twins was selected from 279 of the 915
families, and a DNA sample was screened for rare variants in GDF9
using denaturant HPLC. Variants were confirmed by DNA sequencing
and genotyped in the entire sample by matrix-assisted laser desorption
ionization time of flight (MALDI-TOF) mass spectrometry.
Results: We found two novel insertion/deletions (c.392-393insT,
c.1268-1269delAA) and four missense alterations in the GDF9 se-
quence in mothers of twins. Two of the missense variants (c.307CT,
p.Pro103Ser and c.362CT, p.Thr121Leu) were located in the pro-
region of GDF9 and two (c.1121CT, p.Pro374Leu and c.1360CT,
p.Arg454Cys) in the mature protein region. For each variant, the
frequencies were higher in cases compared with controls. The pro-
portion of mothers of DZ twins carrying any variant (4.12%) was
significantly higher (P  0.0001) than the proportion of carriers in
controls (2.29%).
Conclusion: We describe new variants in the GDF9 gene that are
significantly more common in mothers of DZ twins than controls,
suggesting that rare GDF9 variants contribute to the likelihood of DZ
twinning. (J Clin Endocrinol Metab 91: 4713–4716, 2006)
VARIATION IN DIZYGOTIC (DZ) twinning has a ge-netic component (1–3) with family studies showing
significantly higher frequencies of DZ twins in female rela-
tives of mothers of DZ twins compared with mothers of
monozygotic (MZ) twins (2, 3). Women with a history of DZ
twinning have an increased incidence of multiple follicle
growth (4, 5), and in other mammals, members of the TGF
superfamily, growth differentiation factor-9 (GDF9), and
bonemorphogenetic protein-15 (BMP15) play crucial roles in
determining follicle growth and ovulation rate (6).
These genes are critical for human fertility. A dominant-
negative mutation in BMP15 in Italian sisters resulted in
ovarian dysgenesis (7), and raremutations in both GDF9 and
BMP15 contribute to premature ovarian failure (POF) (8–10).
We previously reported a heterozygous loss-of-functionmu-
tation in the pro-region of GDF9 in two sisters with spon-
taneous DZ twins (11), and rare mutations in GDF9 may
contribute to an increased frequency of twins in some fam-
ilies. We therefore conducted a screen for GDF9 variants in
mothers of spontaneous DZ twins and assessed the fre-
quency of the variants in DZ twinning families.
Subjects and Methods
Study subjects were recruited from 915 families with a history of DZ
twinning [755 families fromAustralia andNewZealand and 160 families
from The Netherlands] with 3450 individuals available for genotyping.
We recruited families with two or more sisters who gave birth to spon-
taneous DZ twins (12) and also families with a single case where at least
one third-degree female relative had DZ twins. Samples were also ob-
tained from parents of mothers of twins where available and from
additional sibs. Mothers of DZ twins and their families were identified
through records from our genetic epidemiology studies using twins and
their families inAustralia (2), through organizations formothers of twins
inAustralia andNewZealand, and through appeals in themedia in both
countries. In The Netherlands, ascertainment was population-based
through community records as part of a systematic recruitment to The
Netherlands Twin Register (3, 13). Mothers were explicitly asked about
fertility treatments, and all such cases were excluded.
Genetic investigation was extended to a population-based control
group of 1512 Caucasian individuals (unselected for twinning history).
Individuals were selected at random from the electoral role in Australia
and enrolled in the study. Study protocols were reviewed and approved
by the QIMR Human Research Ethics Committee and the Ethics Com-
mittee of the Vrije Universiteit Hospital. Participation was voluntary,
and each participant gave written informed consent.
Genetic analysis
The entire coding sequence and intron-exon junctions of the GDF9
gene were analyzed in 279 mothers of DZ twins (one woman from 279
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of our 915 sister pair families). Samples were screened by denaturant
HPLC of PCR-amplified fragments on a Varian Helix System (Varian,
Walnut Creek, CA). Variants were confirmed by DNA sequencing from
new PCR products (Applied Biosystems, Foster City, CA).
Assays for all confirmed variants plus two missense mutations
c.199A.C (p.Lys67Glu) and c.646G.A (p.Val216Mat) reported by Dixit et
al. (9)were designed and genotyped in all study subjects using a compact
matrix-assisted laser desorption ionization time of flight (MALDI-TOF)
Mass Spectrometer (Sequenom Inc., SanDiego). The potential functional
significance of missense mutations was predicted using the Align-
GVGD program (14) (available at http://agvgd.iarc.fr) with a multiple
sequence alignment formammalianGDF9protein sequences. Frequency
differenceswere tested by contingency 2 testingwith 2 and asymptotic
P values estimated, allowing for the family nature of the data as im-
plemented in MENDEL 6.0 (15). To assess the significance of frequency
differences between cases and controls, the likelihood for a family con-
taining an individual who was sequenced was corrected by dividing by
the likelihood of observing the variant in the discovery phase.
Results
We identified six new variants within the coding region of
GDF9. One mutation (c.1268-1269delAA) resulted in a 2-bp
deletion in exon 2 at position 1268. The deletion introduced a
frame shift resulting in a premature stop codon 10 amino acids
downstream of the deletion and truncation of the mature pro-
tein in the putative translation product. A second mutation
(c.392-393insT) resulted in a single base insertion in exon 1 at
position 393 in the pro-region. The insertion also introduced a
frame shift resulting in a premature stop codon at amino acid
position 143.Wedetected fourmissense alterations in theGDF9
sequence in mothers of twins. Two variants (c.307CT,
p.Pro103Ser and c.362CT, p.Thr121Leu) were located in the
pro-regionofGDF9, and twovariants (c.1121CT,p.Pro374Leu
and c.1360CT, p.Arg454Cys) were located in the mature pro-
tein region.
We typed five of these variants (c.1268-1269delAA and the
missense mutations) in 915 families with a history of DZ
twinning including 1693 mothers of DZ twins with genotype
data (Table 1). The c.1268-1269delAA deletion mutation was
detected in two families and in each family was carried by
both sisters with DZ twins. One individual carrying the
mutation had three sets of DZ twins (Fig. 1). The allele fre-
quencies of the five variants were also compared with fre-
quencies in the control group. For each variant, the frequency
in cases was greater than the frequency in controls (Table 1).
The variants c.1268-1269delAA and p.Pro374Leu were not
observed in control samples, and the difference between
cases and controls was significant for c.1268-1269delAA,
p.Pro103Ser, and p.Pro374Leu. Considered together, the fre-
quency of any of the five variants in GDF9 in mothers of
twins was twice the frequency in the controls (P  0.0001).
The difference was still significant (P  0.0026) if only Aus-
tralia and New Zealand families were compared with con-
trols. The relative risk for carrying a GDF9 variant was 2.15
(95% confidence interval, 1.42–3.24). Because these variants
were carried by 2.2% of controls, the attributable risk for
twinning due to these five variantswas 2.4% (95% confidence
interval , 0.9–4.7). Nomothers of twins in our sample carried
the missense mutations in GDF9 reported in Indian POF
patients.
Discussion
GDF9 is an oocyte-derived growth factor essential for fol-
licle growth. We previously reported a heterozygous loss-of-
function mutation in GDF9 in two sisters with spontaneous
DZ twins (11). We have now identified six additional rare
variants in GDF9 in mothers of DZ twins. After ascertain-
ment correction, equivalent to the classic correction of re-
moving the proband variants from the counts for cases before
doing the comparison, the frequency of all novel variantswas
significantly higher in mothers of DZ twins compared with
a population-based control group. Frequencies for three in-
dividual variants (c.1268-1269delAA, p.Pro103Ser, and
p.Pro374Leu) were significantly higher in cases compared
with controls.
We observed a low frequency of functional variantswithin
our control group, but this might be expected. Functional
variants in GDF9 are unlikely to cause twin ovulations at all
cycles, and not all twin ovulations will result in twin preg-
nancies due to partial failure of such pregnancies (“vanishing
twins”) (16). The penetrance (defined as the chance of having
twins when carrying a functional variant) is expected to be
low, as suggested by observations of low concordance rates
of femaleMZ twins giving birth to DZ twins (2). The controls
comprised both sexes, and females were unselected with
respect to reproductive history.
The significantly higher frequency of GDF9 variants in
mothers of twins suggests that some variants may be func-
tional. Two of the novel variants were insertion/deletion
mutations that introduce stop codons immediately down-
stream, increasing the number of truncating mutations in
GDF9 observed in sister pairs with spontaneous DZ twins to
TABLE 1. Number of heterozygous carriers (Het) and minor allele frequencies (Freq) of variants identified in GDF9 in 915 DZ twinning
families (with 1693 mothers of DZ twins) and in 1512 control samples
GDF9 variant Protein variant
Cases Controls
P value
Heta Freqb Het Freq
c.307CT Pro103Ser 30 0.0119 13 0.0048 0.02886
c.362CT Thr121Leu 4 0.0010 1 0.0004 0.20362
c.1121CT Pro374Leu 4 0.0019 0 0 0.00842
c.1268–1269delAA Frame shift 4 0.0020 0 0 0.03574
c.1360CT Arg454Cys 22 0.0067 12 0.0044 0.12986
Any of the above 0.0229 0.0111 0.00015
P values were calculated for the likelihood ratio test (MENDEL binomial link measured genotype model), testing for effect of the variant
on the likelihood of having twins under a multiplicative model.
a Numbers of mothers of twins carrying heterozygous GDF9 variants.
b Minor allele frequencies of GDF9 variants.
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three (11). The c.1268-1269delAA heterozygous deletion was
present in two pairs of sisters with DZ twins. One of the
women had three sets of twins, supporting the view that the
deletion mutation increases the frequency of twinning. The
other women all had a single set of twins as well as other
singleton pregnancies, consistent with the expectation that
functional variants in genes influencing twinning will have
low penetrance. Overall, the increase in twinning frequency
is lower than the effect of loss-of-functionmutations in GDF9
in sheep (17) and probably reflects species differences in
ovulation rate and twinning frequency (6).
The four other novel variants detected were all missense
mutations. GDF9, like other members of the TGF family, is
synthesized as a preproprotein. After cleavage of the signal
peptide, the GDF9 proprotein forms homodimers and het-
erodimers with BMP15. Naturally occurring variants in
BMP15 and GDF9 affect normal processing of the proprotein
dimers (18). Amino acid substitutions are more likely to
influence protein function when differences in the biochem-
ical properties are large and the amino acids are located at
residues highly conserved between species. Prediction of the
likely effects of the mutations (14) suggests that three of the
variants (p.Pro103Ser, p.Pro374Leu, and p.Arg454Cys) are
important amino acid substitutions at positions conserved in
all mammalian GDF9 proteins and are expected to be dele-
terious. The proline at position 374 and the arginine at po-
sition 454 are also conserved in chicken and zebrafish se-
quences, providing further evidence that these substitutions
are likely to have functional consequences. The p.Thr121Leu
substitution is also predicted to be deleterious, but with
weaker evidence because this amino acid position is not
invariant in all mammalian species. Both changes affecting
the proline residues were significantly higher in mothers of
DZ twins, but not the p.Arg454Cys change.
The demonstration of rare alleles contributing to DZ twin-
ning provides an example of rare variants contributing to a
common phenotype. We have previously shown no associ-
ation between common variation in GDF9 and DZ twinning
(11). Recent papers describe rare variants in both GDF9 and
BMP15 contributing to POF (7–10, 19) showing that rare
variants in these two genes influence human fertility. The
attributable risk for twinning associatedwith rare variants in
GDF9 is small (2.4%), and it is estimated that several hundred
similar variants would be required to explain the observed
level of familial aggregation for DZ twinning. It is possible
that rare variants from other genes in pathways regulating
ovarian follicle growth and maturation (including BMP15)
also contribute to variation in twinning.
The results also imply a more direct relationship between
twinning and POF. Mothers of DZ twins reach menopause
significantly earlier than mothers of MZ twins with the dif-
ference occurring before age 40 (20). The small increase in the
frequency of POF in mothers of DZ twins could be explained
by mutations in GDF9 and BMP15 influencing both aspects
of ovarian function, although none of our mothers of twins
carried the missense mutations reported in Indian POF pa-
tients (9). Future studies should examine whether the same
variants in GDF9 and BMP15 affect both twinning and POF
via commonmechanisms orwhether different variants affect
these two phenotypes.
In conclusion, we identified six novel variants in GDF9 in
mothers of DZ twins. Two of the variants were insertion/
deletion mutations, with one mutation detected in a woman
with three sets of twins. GDF9 gene variants were signifi-
cantly more prevalent among mothers of DZ twins than
controls. Additional studieswill be required to determine the
effect of these variants on GDF9 function.
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